Concepedia

Walter Grundy

WG

Statistics

Publications

2

Citations

614

H-Index

2

Active since

1997

Affiliations

AstraZeneca (United Kingdom)(Current)

Walter Grundy is an author at AstraZeneca (United Kingdom) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

1997–2001

2

Publications

2

Studies leading to the identification of ZD1839 (iressa™): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer

Andrew Barker, Keith H. Gibson, Walter Grundy et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 559 citations · Full text

, , +10

Epidermal growth factor receptor tyrosine kinase: Structure-activity relationships and antitumour activity of novel quinazolines

Keith H. Gibson, Walter Grundy, Andrew A. Godfrey et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 55 citations

, , +9

1–2 of 2